Hosted on Acast. See acast.com/privacy for more information.
]]>Hosted on Acast. See acast.com/privacy for more information.
]]>They discuss the challenges of distributing temperature and light-sensitive investigational medicinal products, the hidden cost of logistics failures, and why quality should not be compromised when limited clinical material and years of development are at risk.
The conversation also examines how trust is built through references, communication, transparency and a genuine understanding of the science behind each shipment. Their key message is that stronger outcomes begin when biotech and logistics teams understand the product, the risks and each other’s responsibilities.
Hosted on Acast. See acast.com/privacy for more information.
]]>They discuss the challenges of distributing temperature and light-sensitive investigational medicinal products, the hidden cost of logistics failures, and why quality should not be compromised when limited clinical material and years of development are at risk.
The conversation also examines how trust is built through references, communication, transparency and a genuine understanding of the science behind each shipment. Their key message is that stronger outcomes begin when biotech and logistics teams understand the product, the risks and each other’s responsibilities.
Hosted on Acast. See acast.com/privacy for more information.
]]>They discuss where temperature deviations most commonly occur, why many cold chain risks arise during handovers and ground operations rather than in the air, and how airlines, freight forwarders and shippers can work more closely together to protect sensitive healthcare products.
The conversation also examines the growing role of tracking technology, the importance of turning visibility into action, and why accountability and ownership remain some of the industry's biggest challenges.
Their key message is that stronger cold chains are built through collaboration, preparation and clear responsibility across every stage of the journey.
Chapters:
0:00 Introduction
1:18 Meet SAS Cargo's Jens Rørbye
3:45 Air Cargo in Life Science Logistics
6:20 Where Temperature Excursions Occur
10:05 Reducing Risk in Cold Chain Shipments
13:45 Shipment Visibility & Tracking Technology
17:10 Building a Connected Logistics Ecosystem
20:25 What Freight Forwarders Can Do Better
24:00 Ownership & Accountability in Air Freight
27:05 Future Improvements for Cold Chain Logistics
28:15 Closing Remarks
Hosted on Acast. See acast.com/privacy for more information.
]]>They discuss where temperature deviations most commonly occur, why many cold chain risks arise during handovers and ground operations rather than in the air, and how airlines, freight forwarders and shippers can work more closely together to protect sensitive healthcare products.
The conversation also examines the growing role of tracking technology, the importance of turning visibility into action, and why accountability and ownership remain some of the industry's biggest challenges.
Their key message is that stronger cold chains are built through collaboration, preparation and clear responsibility across every stage of the journey.
Chapters:
0:00 Introduction
1:18 Meet SAS Cargo's Jens Rørbye
3:45 Air Cargo in Life Science Logistics
6:20 Where Temperature Excursions Occur
10:05 Reducing Risk in Cold Chain Shipments
13:45 Shipment Visibility & Tracking Technology
17:10 Building a Connected Logistics Ecosystem
20:25 What Freight Forwarders Can Do Better
24:00 Ownership & Accountability in Air Freight
27:05 Future Improvements for Cold Chain Logistics
28:15 Closing Remarks
Hosted on Acast. See acast.com/privacy for more information.
]]>Hosted on Acast. See acast.com/privacy for more information.
]]>Hosted on Acast. See acast.com/privacy for more information.
]]>Niklas emphasizes that success in this critical industry comes down to people, processes, and technology. Proper training, clear responsibilities, and trust are key to keeping medicines safe and reaching the patients who need them.
Hosted on Acast. See acast.com/privacy for more information.
]]>Niklas emphasizes that success in this critical industry comes down to people, processes, and technology. Proper training, clear responsibilities, and trust are key to keeping medicines safe and reaching the patients who need them.
Hosted on Acast. See acast.com/privacy for more information.
]]>advanced therapies such as cell and gene treatments. We'll talk about how these
therapies are impacted by shipment disruptions and the importance of early cold chain
planning. The conversation will also touch on collaboration with CDMOs and logistics
providers, as well as broader reflections on where the industry needs to improve.
Hosted on Acast. See acast.com/privacy for more information.
]]>advanced therapies such as cell and gene treatments. We'll talk about how these
therapies are impacted by shipment disruptions and the importance of early cold chain
planning. The conversation will also touch on collaboration with CDMOs and logistics
providers, as well as broader reflections on where the industry needs to improve.
Hosted on Acast. See acast.com/privacy for more information.
]]>